Final days should be interesting. Can anybody see any advantage for a competitor to ZFX, actually waiting till the final days to launch their bid??I can't see it happening, but I assume that's what is weighing on some people's minds.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status